HC Wainwright & Co. Reiterates Buy on Zentalis Pharmaceuticals, Maintains $10 Price Target
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsReiterationPrice Target
HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Zentalis Pharmaceuticals (NASDAQ:ZNTL) with a Buy and maintains $10 price target.
HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Zentalis Pharmaceuticals (NASDAQ:ZNTL) with a Buy and maintains $10 price target.